493 related articles for article (PubMed ID: 4451752)
1. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
Pertwee RG
Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
[TBL] [Abstract][Full Text] [Related]
2. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
Lawrence DK; Pertwee RG
Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
[TBL] [Abstract][Full Text] [Related]
3. Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol.
Fitton AG; Pertwee RG
Br J Pharmacol; 1982 Feb; 75(2):409-14. PubMed ID: 6313110
[TBL] [Abstract][Full Text] [Related]
4. Interaction of ambient temperature with the effects of delta 9-tetrahydrocannabinol on brain catecholamine synthesis and plasma corticosterone levels.
Bloom AS; Kiernan CJ
Psychopharmacology (Berl); 1980; 67(3):215-9. PubMed ID: 6247738
[TBL] [Abstract][Full Text] [Related]
5. The effects of (-)-delta9-tetrahydrocannabinol on reserpine-induced hypothermia in rats.
Englert LF; Ho BT; Taylor D
Br J Pharmacol; 1973 Oct; 49(2):243-52. PubMed ID: 4793331
[TBL] [Abstract][Full Text] [Related]
6. The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice.
Chesher GB; Dahl CJ; Everingham M; Jackson DM; Marchant-Williams H; Starmer GA
Br J Pharmacol; 1973 Dec; 49(4):588-94. PubMed ID: 4788032
[TBL] [Abstract][Full Text] [Related]
7. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute and subchronic delta 9-tetrahydrocannabinol administration on the plasma catecholamine, beta-endorphin, and corticosterone levels and splenic natural killer cell activity in rats.
Patel V; Borysenko M; Kumar MS; Millard WJ
Proc Soc Exp Biol Med; 1985 Nov; 180(2):400-4. PubMed ID: 2996013
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
[TBL] [Abstract][Full Text] [Related]
10. Reduction by 9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands.
Birmingham MK
Br J Pharmacol; 1973 May; 48(1):169-71. PubMed ID: 4724188
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.
Lindgren JE; Ohlsson A; Agurell S; Hollister L; Gillespie H
Psychopharmacology (Berl); 1981; 74(3):208-12. PubMed ID: 6267648
[TBL] [Abstract][Full Text] [Related]
12. Delta(9)-tetrahydrocannabinol enhances an increase of plasma corticosterone levels induced by forced swim-stress.
Sano K; Koushi E; Irie K; Higuchi S; Tsuchihashi R; Kinjo J; Egashira N; Oishi R; Uchida N; Nagai H; Nishimura R; Tanaka H; Morimoto S; Mishima K; Iwasaki K; Fujiwara M
Biol Pharm Bull; 2009 Dec; 32(12):2065-7. PubMed ID: 19952430
[TBL] [Abstract][Full Text] [Related]
13. The effects of delta1-tetrahydrocannabinol on mammary gland growth, enzyme activity and plasma prolactin levels in the mouse.
Raine JM; Wing DR; Paton WD
Eur J Pharmacol; 1978 Sep; 51(1):11-7. PubMed ID: 699971
[TBL] [Abstract][Full Text] [Related]
14. The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice.
Pertwee RG
Br J Pharmacol; 1972 Dec; 46(4):753-63. PubMed ID: 4655271
[TBL] [Abstract][Full Text] [Related]
15. Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.
Hayakawa K; Mishima K; Nozako M; Hazekawa M; Ogata A; Fujioka M; Harada K; Mishima S; Orito K; Egashira N; Iwasaki K; Fujiwara M
Life Sci; 2007 Mar; 80(16):1466-71. PubMed ID: 17289082
[TBL] [Abstract][Full Text] [Related]
16. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
Watanabe K; Yamamoto I; Yoshimura H
Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cannabis and general anaesthetic agents in mice.
Chesher GB; Jackson DM; Starmer GA
Br J Pharmacol; 1974 Apr; 50(4):593-9. PubMed ID: 4280927
[TBL] [Abstract][Full Text] [Related]
18. Adrenalectomy reverses the effects of delta-9-THC on mouse brain 5-hydroxytryptamine turnover.
Johnson KM; Dewey WL; Bloom AS
Pharmacology; 1981; 23(4):223-9. PubMed ID: 6275421
[TBL] [Abstract][Full Text] [Related]
19. Lack of tolerance to 9 -tetrahydrocannabinol in chimpanzees.
Ferraro DP; Grilly DM
Science; 1973 Feb; 179(4072):490-2. PubMed ID: 4705343
[TBL] [Abstract][Full Text] [Related]
20. Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: evidence of an acute effect and development of tolerance in chronic treatments.
RodrÃguez de Fonseca F; Fernández-Ruiz JJ; Murphy L; Eldridge JC; Steger RW; Bartke A
Pharmacol Biochem Behav; 1991 Nov; 40(3):593-8. PubMed ID: 1687229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
